Ocean Biomedical Debuts as Publicly Traded Company
By Healthcare Edge Editorial Staff Biopharma company Ocean Biomedical (Nasdaq: OCEA) began trading publicly today after merging with a SPAC called Aesther Healthcare Acquisition Corp. (Nasdaq: AEHA). Ocean Biomedical is focused on the commercialization of assets from research universities...